News Detail

New Delhi, 4 March 2024: The Delhi High Court has said that custom duties and charges will not be applied to medicines, drugs, and therapies used for treating rare diseases.
This decision comes as a relief to patients suffering from conditions such as Duche......
View Details
Source : DrugsControl Media Services
Master Arnesh Shaw vs Union of India & Anr
Delhi High Court
W.P.(C) 5315/2020 & CM Appl. 19189/2020
4237/2023
D/d 26.2.2024
2024:DHC:1687
Duchenne Muscular Dystrophy
Hunter's syndrome
Related News
- NPPA asks retailers, dealers and online pharmacies to ensure compliance of Para 24 and 25 of DPCO, 2013 (11-02-2025)
- Kerala: 12 establishments caught selling fake cosmetics, including soaps and creams, with harmful chemicals (11-02-2025)
- EMA establishes regular procedure for scientific advice on certain high-risk medical devices (11-02-2025)
- Goyal urges the pharmaceutical industry to expose those engaged in sale of counterfeit products (11-02-2025)
- WHO identifies research priorities for boosting fight against antimicrobial resistance (11-02-2025)
- Supreme Court Calls on State Officials to Address Misleading Drug Advertisements (10-02-2025)
- Cases will be initiated immediately against individuals involved in sale of intoxicants and adulteration of drugs (10-02-2025)
- An index to gauge states for drug enforcement, improve drug quality (10-02-2025)
- China's health regulator defends quality of local generic drugs (10-02-2025)
- DGFT amends standard input output norms for erythromycin stearate tablets (10-02-2025)